Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KCT0006288Phase 4Completed
A Phase 4 trial of remimazolam, sponsored by Yonsei University Wonju College of Medicine. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on KCT0006288.